Skip to main content
Top
Literature
1.
go back to reference Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K (1982) Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 100:272–278CrossRefPubMed Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K (1982) Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 100:272–278CrossRefPubMed
3.
go back to reference Vincent A, McAlister C, VandenHoven C, Héon E (2011) BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies. Eye 25:113–118CrossRefPubMed Vincent A, McAlister C, VandenHoven C, Héon E (2011) BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies. Eye 25:113–118CrossRefPubMed
4.
go back to reference Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, Perveen R, Reddy MA, Bhattacharya SS, Traboulsi E, Baralle D, De Laey JJ, Puech B, Kestelyn P, Moore AT, Manson FD, Black GC (2004) Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 45(10):3683–3689CrossRefPubMed Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, Perveen R, Reddy MA, Bhattacharya SS, Traboulsi E, Baralle D, De Laey JJ, Puech B, Kestelyn P, Moore AT, Manson FD, Black GC (2004) Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 45(10):3683–3689CrossRefPubMed
5.
go back to reference Roider J, Fritsch E, Hoerauf H, Heide W, Laqua H (1997) Autosomal dominant vitreoretinochoroidopathy. Retina 17:294–299CrossRefPubMed Roider J, Fritsch E, Hoerauf H, Heide W, Laqua H (1997) Autosomal dominant vitreoretinochoroidopathy. Retina 17:294–299CrossRefPubMed
6.
go back to reference Lafaut BA, Loeys B, Leroy BP, Spileers W, De Laey JJ, Kestelyn P (2001) Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol 239(8):575–582CrossRefPubMed Lafaut BA, Loeys B, Leroy BP, Spileers W, De Laey JJ, Kestelyn P (2001) Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch Clin Exp Ophthalmol 239(8):575–582CrossRefPubMed
7.
go back to reference Chen CJ, Goldberg MF (2016) Progressive cone dysfunction and geographic atrophy of the macula in late-stage autosomal dominant vitreoretinochoroidopathy (ADVIRC). Ophthalmic Genet 37(1):81–85CrossRefPubMed Chen CJ, Goldberg MF (2016) Progressive cone dysfunction and geographic atrophy of the macula in late-stage autosomal dominant vitreoretinochoroidopathy (ADVIRC). Ophthalmic Genet 37(1):81–85CrossRefPubMed
Metadata
Title
Long-term changes in autosomal dominant vitreoretinochoroidopathy (ADVIRC)
Authors
L Wöster
J Roider
Publication date
01-02-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3810-y

Other articles of this Issue 2/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2018 Go to the issue